Avanos Medical (AVNS) FCF Margin (2016 - 2024)
Historic FCF Margin for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to 11.74%.
- Avanos Medical's FCF Margin fell 29700.0% to 11.74% in Q3 2024 from the same period last year, while for Dec 2024 it was 16.31%, marking a year-over-year increase of 141400.0%. This contributed to the annual value of 2.17% for FY2023, which is 83000.0% down from last year.
- Avanos Medical's FCF Margin amounted to 11.74% in Q3 2024, which was down 29700.0% from 12.75% recorded in Q2 2024.
- Avanos Medical's 5-year FCF Margin high stood at 132.4% for Q4 2021, and its period low was 7.28% during Q1 2024.
- Over the past 5 years, Avanos Medical's median FCF Margin value was 3.92% (recorded in 2023), while the average stood at 10.31%.
- Per our database at Business Quant, Avanos Medical's FCF Margin surged by 1345600bps in 2021 and then crashed by -1165400bps in 2022.
- Quarter analysis of 5 years shows Avanos Medical's FCF Margin stood at 2.16% in 2020, then surged by 6224bps to 132.4% in 2021, then plummeted by -88bps to 15.86% in 2022, then plummeted by -75bps to 3.92% in 2023, then surged by 199bps to 11.74% in 2024.
- Its FCF Margin was 11.74% in Q3 2024, compared to 12.75% in Q2 2024 and 7.28% in Q1 2024.